Oregon State University researchers have found that using nanotechnology with heat and cytotoxic drugs can kill up to 95% of ovarian cancer cells. While there is still additional research that needs to be done, the results of the initial study are promising for the future of ovarian cancer treatments. Read full article here.
A new study released in Lancet Oncology showed that abnormal levels of female hormones in the bloodstream may be why women with BRCA1 or BRCA2 mutations are at a higher risk for breast and ovarian cancer and not other cancers. UCL Department of Women’s Cancer completed the study that found different levels of the female hormones … Continued
A new study conducted by Cancer Research UK has identified chemical “tags” on DNA in patients’ tumors that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive. The research was published in Clinical Cancer Research. These tags, known as epigenetic markers, could be used to assess whether patients will … Continued
A study led by Dr. Andrew Stephens from the Prince Henry’s Institute has discovered a process that is associated with inflammation in cancers. This discovery could lead to expanded treatment options for some types of ovarian cancer tumors. Monash Health, Hasanuddin University, Indonesia and Lincoln Research Centre, Christchurch also participated in the study which was … Continued
The European Cancer Congress convened in Amsterdam, the Netherlands from September 27 – October 1, 2013. The European Cancer Congress in the main multidisciplinary and multi-professional educational meeting in oncology to take place in Europe. At ECCO, cancer specialists from around the world convene to present their research. In this story on Medscape, Dr. Stanley … Continued
Research published in Sept. 2013 in the Journal of Clinical Oncology show that patients with cancer who were married at the time of diagnosis live markedly longer compared to unmarried patients. The results, based on a large retrospective study of the National Cancer Institute’s SEER database, also report that married patients are more likely to … Continued
SHARE got its start in 1976 when Dr. Eugene Thiessen, an oncologist and surgeon, invited survivors to meet informally at the Manhattan breast cancer clinic he founded. “At the time, people were not comfortable uttering the words ‘breast’ and ‘cancer’ out loud. The notion of peer support was truly innovative,” says Jacqueline Reinhard, SHARE’s executive … Continued
Many Americans will begin shopping for health insurance on October 1 through the new insurance marketplaces. As a cancer patient, you have unique health care needs that you may want to consider. The Ovarian Cancer National Alliance has partnered with 18 patient advocacy organizations to launch a new tool that will help you pick the … Continued
Dr. Ron Chandler is a 2013 Ann Schreiber Mentored Investigator Award recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Chandler discusses his research and what it means to receive a grant from OCRF. Sarah DeFeo: Tell us about yourself. Ron Chandler: I am the first Ph.D. scientist in my family, although my Grandpa and Dad … Continued
A new study released today by MD Anderson Cancer Center in Texas shows that a family of microRNAs (miR-200) blocks cancer progression by cutting off the tumor’s ability to build new blood vessels. These findings highlight the potential of biomarkers for identifying patients who might benefit from treatment. Dr. Anil Sood says “safety studies will need … Continued
Washington, DC—A new report released by the Ovarian Cancer National Alliance summarizes the experiences of 1,014 women diagnosed with ovarian cancer. Based on a survey conducted by the Alliance in partnership with Inspire, the report details how women were diagnosed and whether their treatment followed national guidelines for ovarian cancer. The survey was inspired by … Continued
Dr. Maria Barbolina is a 2013 Liz Tilberis Early Career Award grant recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Barolina discusses her research and what it means to receive a grant from OCRF. Sarah DeFeo: Tell us a little about yourself. Maria Barbolina: I live in Chicago now, but my life started on the … Continued
Get email updates about research news, action alerts, and ways to join the fight.
